Abstract
Endothelial cell growth factor has been recently proposed as a potential autoantigen in manifestations of Lyme disease that are thought to involve immune-mediated mechanisms. Our findings indicate that a humoral immune response to this protein is not associated with posttreatment Lyme disease syndrome.
Author supplied keywords
Cite
CITATION STYLE
APA
Tang, K. S., Klempner, M. S., Wormser, G. P., Marques, A. R., & Alaedini, A. (2015). Association of immune response to endothelial cell growth factor with early disseminated and late manifestations of lyme disease but not posttreatment lyme disease syndrome. Clinical Infectious Diseases, 61(11), 1703–1706. https://doi.org/10.1093/cid/civ638
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free